__timestamp | Ionis Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 214161000 | 122045000 |
Thursday, January 1, 2015 | 283703000 | 144427000 |
Friday, January 1, 2016 | 346620000 | 215003000 |
Sunday, January 1, 2017 | 507666000 | 302238000 |
Monday, January 1, 2018 | 599674000 | 408897000 |
Tuesday, January 1, 2019 | 1123000000 | 392755000 |
Wednesday, January 1, 2020 | 729000000 | 520397000 |
Friday, January 1, 2021 | 810000000 | 579775000 |
Saturday, January 1, 2022 | 587000000 | 667238000 |
Sunday, January 1, 2023 | 787647000 | 607521000 |
Monday, January 1, 2024 | 705138000 |
Cracking the code
In the competitive landscape of pharmaceuticals, revenue generation is a key indicator of success. Over the past decade, Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have been vying for dominance. From 2014 to 2023, Ionis consistently outperformed Supernus, with a peak revenue in 2019 that was nearly double that of Supernus. However, the gap has been narrowing. By 2022, Supernus achieved a revenue of approximately 667 million, surpassing Ionis for the first time. This shift highlights Supernus's strategic growth, marking a 447% increase from its 2014 revenue. Meanwhile, Ionis's revenue trajectory shows fluctuations, with a notable dip in 2022. As we look to the future, the question remains: will Supernus maintain its momentum, or will Ionis reclaim its lead? This dynamic rivalry underscores the ever-evolving nature of the pharmaceutical industry.
Annual Revenue Comparison: Novartis AG vs Ionis Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Dr. Reddy's Laboratories Limited vs Ionis Pharmaceuticals, Inc.
Revenue Insights: Catalent, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Exelixis, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Ascendis Pharma A/S and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Ionis Pharmaceuticals, Inc. or ACADIA Pharmaceuticals Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Ionis Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Showdown: PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Perrigo Company plc and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Supernus Pharmaceuticals, Inc.